Nature Publishing Group, publisher of Nature, and other science journals and reference works
Nature
my account e-alerts subscribe register
SEARCH JOURNAL     advanced search
Journal Home
Current Issue
AOP
Archive
Download PDF
References
Export citation
Export references
Send to a friend
More articles like this

Letters to Nature
Nature 384, 458 - 460 (05 December 1996); doi:10.1038/384458a0

Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)

Kazuya Yamagata*, Hiroto Furuta*, Naohisa Oda*, Pamela J. Kaisaki*, Stephan Menzel*, Nancy J. Cox*, Stefan S. Fajans, Stefano Signorini, Markus Stoffel & Graeme I. Bell*

* Howard Hughes Medical Institute, and Departments of Biochemistry & Molecular Biology, and Medicine, The University of Chicago, 5841 South Maryland Avenue, MC1028, Chicago, Illinois 60637, USA
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA
Laboratory of Metabolic Diseases, Rockefeller University, New York, New York 10021, USA

THE disease maturity-onset diabetes of the young (MODY) is a genetically heterogeneous monogenic form of non-insulin-dependent (type 2) diabetes mellitus (NIDDM), characterized by early onset, usually before 25 years of age and often in adolescence or childhood, and by autosomal dominant inheritance1. It has been estimated that 2−5% of patients with NIDDM may have this form of diabetes mellitus2,3. Clinical studies have shown that predia-betic MODY subjects have normal insulin sensitivity but suffer from a defect in glucose-stimulated insulin secretion, suggesting that pancreatic beta-cell dysfunction rather than insulin resistance is the primary defect in this disorder4,5. Linkage studies have localized the genes that are mutated in MODY on human chromosomes 20 (MODY1)6, 7 (MODY2)2 and 12 (MODY3}7, with MODY2 and MODY3 being allelic with the genes encoding glucokinase2, a key regulator of insulin secretion, and hepatocyte nuclear factor-1alpha (HNF-1alpha)8, a transcription factor involved in tissue-specific regulation of liver genes but also expressed in pancreatic islets, insulinoma cells and other tissues. Here we show that MODY1 is the gene encoding HNF-4alpha (gene symbol, TCP14), a member of the steroid/thyroid hormone receptor superfamily and an upstream regulator of HNF-1alpha expression9−11.

  1. Fajans, S. S. Diab./Metabol. Rev. 5, 579−606 (1989). | ChemPort |
  2. Froguel, P. et al. N. Engl. J. Med. 328, 697−702 (1993). | Article | PubMed | ISI | ChemPort |
  3. Ledermann, H. M. Lancet 345, 648 (1995). | Article | PubMed | ChemPort |
  4. Herman, W. H. et al. Diabetes 43, 40−46 (1994) [erratum, Diabetes 43, 1171 (1994)].
  5. Byrne, M. M. et al. Diabetes 44, 699−704 (1995). | PubMed | ISI | ChemPort |
  6. Bell, G. I. et al. Proc. Natl Acad. Sci. USA 88, 1484−1488 (1991). | PubMed | ChemPort |
  7. Vaxillaire, M. et al. Nature Genet. 9, 418−423 (1995). | Article | PubMed | ISI | ChemPort |
  8. Yamagata, K. et al. Nature 384, 455−458 (1996). | Article | PubMed | ISI | ChemPort |
  9. Sladek, F. M., Zhong, W., Lai, E. & Darnell, J. E. Jr Genes Dev. 4, 2353−2365 (1990). | PubMed | ISI | ChemPort |
  10. Kuo, C. J. et al. Nature 355, 457−461 (1992). | Article | PubMed | ISI | ChemPort |
  11. Mangelsdorf, D. J. et al. Cell 83, 835−839 (1995). | Article | PubMed | ISI | ChemPort |
  12. Fajans, S. S., Bell, G. I., Bowden, D. W., Halter, J. B. & Polonsky, K. S. Life Sci. 55, 413−422 (1994). | Article | PubMed | ChemPort |
  13. Irwin, M., Cox, N. & Kong, A. Proc. Natl Acad. Sci. USA 91, 11684−11688 (1994). | PubMed | ChemPort |
  14. Stoffel, M. et al. Proc. Natl Acad. Sci. USA 93, 3939−3941 (1996).
  15. Chartier, F. L., Bossu, J.-P., Laudet, V., Fruchart, J.-C. & Laine, B. Gene 147, 269−272 (1994). | Article | PubMed | ISI | ChemPort |
  16. Xanthopoulos, K. G. et al. Proc. Natl Acad. Sci. USA 88, 3807−3811 (1991). | PubMed | ChemPort |
  17. Miquerol, L. et al. J. Biol. Chem. 269, 8944−8951 (1994). | PubMed | ISI | ChemPort |
  18. Chen, W. S. et al. Genes Dev. 8, 2466−2477 (1994). | PubMed | ISI | ChemPort |
  19. Emens, L. A., Landers, D. W. & Moss, L. G. Proc. Natl Acad. Sci. USA 89, 7300−7304 (1992). | PubMed | ChemPort |
  20. Zhang, X.-K., Salbert, G., Lee, M.-O. & Pfahl, M. Mol. Cell. Biol. 14, 4311−4323 (1994). | PubMed | ChemPort |
  21. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H. & Moras, D. Nature 375, 377−382 (1995). | Article | PubMed | ISI | ChemPort |
  22. Renaud, J.-P. et al. Nature 378, 681−689 (1995). | Article | PubMed | ISI | ChemPort |
  23. Wagner, R. L. et al. Nature 378, 690−697 (1995). | Article | PubMed | ISI | ChemPort |
  24. Byrne, M. M. et al. Diabetes 45, 1503−1510 (1996). | PubMed | ISI | ChemPort |
  25. Hanis, C. L. et al. Nature Genet. 13, 161−166 (1996). | Article | PubMed | ISI | ChemPort |
  26. Iwasaki, N. et al. J. Japan. Diab. Soc. 39, 409−416 (1996).
  27. Polonsky, K. S., Sturis, J. & Bell, G. I. N. Engl. J. Med. 334, 777−783 (1996). | Article | PubMed | ISI | ChemPort |
  28. Drewes, T., Senkel, S., Holewa, B. & Ryffel, G. U. Mol. Cell. Biol. 16, 925−931 (1996). | PubMed | ChemPort |
  29. Tavaviras, S., Monaghan, A. P., Schütz, G. & Kelsey, G. Mech. Dev. 48, 67−79 (1994). | Article | PubMed | ISI | ChemPort |



© 1996 Nature Publishing Group
Privacy Policy